NIH begins clinical trial of hydroxychloroquine and azithromycin to treat COVID-19
Thursday, May 14, 2020 - 16:30
in Health & Medicine
A clinical trial has begun to evaluate whether the malaria drug hydroxychloroquine, given together with the antibiotic azithromycin, can prevent hospitalization and death from coronavirus disease 2019 (COVID-19). The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, is sponsoring the trial, which is being conducted by the NIAID-funded […]